EVFM 2018 Proxy Statement

25 EQUITY COMPENSATION PLAN INFORMATION The following table provides certain aggregate information with respect to all of our equity compensation plans in effect as of December 31, 2017: Plan Category Number of Securities to be Issued Upon Exercise of Awards (a) Weighted Average Exercise Price of Outstanding Awards Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a)) Equity compensation plans approved by Stockholders (1) 407,058 (2) $ 30.98 536,370 (3) Total: 407,058 $ 30.98 536,370 (1) This table does not include the number of shares issuable upon exercise of issued and outstanding awards under the Evofem Operations Equity Incentive Plan. No new awards may be issued under the Evofem Operations Equity Incentive Plan. As of February 28, 2018, a total of 159,325 shares of our common stock were reserved for issuance upon the exercise of outstanding options under the Evofem Operations Equity Incentive Plan with a weighted average exercise price of $56.72 per share. (2) Includes our 2007 Plan and the 2014 Plan. (3) As of December 31, 2017, an aggregate of 366,249 shares of common stock were available for grant under the 2014 Plan and an aggregate of 95,741 shares were available for issuance under 2014 ESPP. The 2014 Plan contains a provision for an automatic increase in the number of shares available for grant each January 1st until and including January 1, 2024, subject to certain limitations, by a number of shares equal to the lesser of 4% of the number of shares of our common stock issued and outstanding on the immediately preceding December 31 or a number of shares set by our board of directors. The ESPP contains a provision for an automatic increase in the number of shares available for issuance under the ESPP each January 1st and including January 1, 2024, subject to certain limitations, by a number of shares equal to the lesser of 1% of our common stock issued and outstanding on the immediately preceding December 31 or a number of shares set by our board of directors.